Sputnik V vaccine 92% effective on COVID-19: Russia institute
Hyderabad:: Sputnik V vaccine for COVID-19, being developed by Russia's Gamaleya National Research Institute of Epidemiology and Microbiology, has demonstrated an efficacy rate of 92 percent.
The confirmation is based on the first interim data from the largest randomized, placebo-controlled Phase-III clinical trials in Russia involving 40,000 volunteers, a press release from Gamaleya, and the Russian Direct Investment Fund (RDIF) said.
The trials evaluated the efficacy among over 16,000 volunteers who received the vaccine or placebo 21 days after the first injection.
As a result of a statistical analysis of 20 confirmed cases of coronavirus, the case split between vaccinated individuals and those who received the placebo indicating that the Sputnik V vaccine had an efficacy rate of 92 percent after the second dose, the release said.
In September 2020, Dr. Reddys and Russian Direct Investment Fund (RDIF), Russias sovereign wealth fund, entered into a partnership to conduct clinical trials of the Sputnik V vaccine and its distribution in India.
As part of the partnership, RDIF shall supply 100 million doses of the vaccine to Dr.Reddys upon regulatory approval in India.
On August 11, 2020, the Sputnik V vaccine was registered by the Ministry of Health of Russia and became the world's first registered vaccine against COVID-19 based on the human adenoviral vectors platform.
Separately, in September the vaccine was first administered to a group of volunteers from the 'red zones' of Russian hospitals.
The observation of additional 10,000 vaccinated volunteers representing medics and other high-risk groups under the civil use of the vaccine out of clinical trials also confirmed the vaccine's efficacy rate of over 90 percent, the release added.
As of November 11, as part of the clinical trials in Russias 29 medical centers, more than 20,000 volunteers were vaccinated with the first dose and over 16,000 volunteers with the first and the second dose of the vaccine.
In addition, as on the date, no unexpected adverse events were identified as part of the research.
Some of those vaccinated had short-term minor adverse effects such as pain at the injection site, flu-like syndrome, including fever, weakness, fatigue, and headache, according to the release.
Alexander Gintsburg, director of Gamaleya Centre, said the publication of the interim results of the post-registration clinical trials that convincingly demonstrate Sputnik V vaccines efficacy gives way to mass vaccination in Russia against COVID-19 in the coming weeks."
Thanks to the production scale-up at new manufacturing sites, the Sputnik V vaccine would soon be available for a wider population, he said.
"This will break the current trend and lead to an eventual decrease in COVID-19 infection rates, first in Russia, then globally," he said.
Pfizer Inc and BioNTech SE on Monday said their vaccine candidate was found to be more than 90 percent effective in preventing COVID-19.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
England sticking with Key, McCullum and Stokes despite Ashes humbling
London (AP): England is not sacking anybody following the 4-1 Ashes loss in Australia.
A review of the tour by the England and Wales Cricket Board, announced within hours of the final match in January, was concluded on Monday. Firing people would “be the easy thing to do,” ECB chief executive Richard Gould said but he insisted, "This is not the time to throw everything out."
Managing director Rob Key, coach Brendon McCullum and captain Ben Stokes kept their jobs after the best England side to go to Australia in 14 years lost the Ashes in 11 days with two games to spare.
“Moving people on can sometimes be the easy thing to do. That's not the route that we're going to take,” Gould said. “I've seen the driving ambition and determination that we're lucky enough to have within our leadership group to take the lessons from the Ashes and move forward.”
Gould previously was the chief executive of Bristol City soccer club and said the ECB would not follow the same route as soccer's hire-and-fire culture.
“Cricket is a very unique sport in that it takes a team of leadership ... it's not like football where there's a single point of failure or success with a manager," he said. He added the ECB would not “select or deselect management based on a popularity campaign.”
The main criticisms of England's tour were poor preparation, player misbehavior, and selection mistakes.
At a press conference at Lord's, Gould and Key said McCullum and Stokes have not had a “bust up,” they did not want McCullum to “completely change” but “to evolve,” the behavior of some players was “unprofessional,” there will be more consequences for underperforming, and a commitment to “better long-term planning” ahead of major test series.
Some changes were already implemented for the Twenty20 World Cup, where England reached the semifinals. Gould implied that performance saved McCullum.
Key acknowledged that England supporters would be disappointed to see the management team go unpunished.
“I know people want punishment and that people then should be sacked for that,” Key said. “That doesn't mean we don't feel like we've gone through some serious pain: Brendon, myself, Ben. It's been as tough a time as I think I've had.”
